 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/04/2026 |
$1.19 |
$1.19 |
$1.10 |
$1.15 |
1.25M | | 02/05/2026 |
$1.12 |
$1.14 |
$1.04 |
$1.05 |
1.75M | | 02/06/2026 |
$1.06 |
$1.14 |
$1.05 |
$1.14 |
1.50M | | 02/09/2026 |
$1.13 |
$1.13 |
$1.07 |
$1.12 |
957.70K | | 02/10/2026 |
$1.13 |
$1.17 |
$1.09 |
$1.09 |
1.41M |
|
|
| Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. Co.'s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. | |
|
Fate Therapeutics (FATE) has the following price history information. Looking back at FATE historical stock prices for the last five trading days, on February 04, 2026, FATE opened at $1.19, traded as high as $1.19 and as low as $1.10, and closed at $1.15. Trading volume was a total of 1.25M shares. On February 05, 2026, FATE opened at $1.12, traded as high as $1.14 and as low as $1.04, and closed at $1.05. Trading volume was a total of 1.75M shares. On February 06, 2026, FATE opened at $1.06, traded as high as $1.14 and as low as $1.05, and closed at $1.14. Trading volume was a total of 1.50M shares. On February 09, 2026, FATE opened at $1.13, traded as high as $1.13 and as low as $1.07, and closed at $1.12. Trading volume was a total of 957.70K shares. On February 10, 2026, FATE opened at $1.13, traded as high as $1.17 and as low as $1.09, and closed at $1.09. Trading volume was a total of 1.41M shares.
FATE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fate Therapeutics shares, starting with a $10,000 purchase of FATE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/12/2016 |
|
| End date: |
02/10/2026 |
|
| Start price/share: |
$1.69 |
|
| End price/share: |
$1.09 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-35.50% |
|
| Average Annual Total Return: |
-4.29% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,449.42 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/04/2026 | $1.15 | | 02/05/2026 | $1.05 | | 02/06/2026 | $1.14 | | 02/09/2026 | $1.12 | | 02/10/2026 | $1.09 |
|
|
Free FATE Email Alerts:
